Clinical Trials Browser

Phase 1 × Pancreatic Neoplasms × motexafin gadolinium × Clear all

Bile Duct Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms

NCT00003798 2012-11-14

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery

Phase 1 Completed

45 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00120939 2009-04-03

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Phase 1 Completed

25 enrolled

BreastCNSGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Recurrence, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Clinical Trials

Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer